Remicaid
Remicaid is a common misspelling of Remicade (infliximab).
What is Remicade (Remicaid)?
Remicade (Remicaid) is a monoclonal antibody. It blocks the action of a substance in the body called tumor necrosis factor (TNF). This may reduce the inflammation and immune responses caused by TNF.
Remicade (Remicaid) is used to treat moderate to severe rheumatoid arthritis when used along with another medicine (methotrexate). Remicade (Remicaid) is also used to reduce symptoms of moderate to severe ankylosing spondylitis, psoriatic arthritis, and certain types of skin psoriasis.
Remicade (Remicaid) is used to reduce symptoms of moderate to severe Crohn disease or ulcerative colitis in patients who have not received relief from other treatments.
Remicade (Remicaid) side effects may include headaches, stomach pain, nausea, swelling ankles/feet, easy bruising/bleeding, vision changes, seizures, confusion, muscle weakness, numbness/tingling of arms/legs, butterfly-shaped facial rash, chest pain, pain/redness/swelling of arms or legs, shortness of breath, fast/slow/irregular heartbeat.
Click for more information on Remicaid (Remicade)
Frequently asked questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What are monoclonal antibodies?
- What are biosimilar drugs?
- What is the difference between Inflectra and Remicade?
- What is the difference between Renflexis and Remicade?
- What are the new drugs for plaque psoriasis?
- How many biosimilars have been approved in the United States?
- What causes Plaque Psoriasis?
- What is the difference between Ixifi and Remicade?
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
